The Nevada Senate May 19 approved a bill, SB 265, that would require drug manufacturers to provide to the department a list of sales representatives who market prescription drugs on their behalf in the state.
The owner and operator of a licensed wholesale distributor of prescription drugs had pleaded guilty to one count of conspiracy to commit health care fraud in connection with the fraudulent distribution operation.
The bill would require drug manufacturers to notify the Department of Health and Human Services and submit a transparency and justification report 30 days before they increase the price of certain drug products.
The FDA Enforcement Letter Database is Thompson Information Services’ exclusive online database of FDA Warning Letters, Untitled Letters and Cyber Letters. The database also contains Determination Letters issued by the U.S. Department of Health and Human Services Office for Human Research Protections. Enforcement letters in the database are searchable by a specific date or a range of dates, letter recipient, product category, regulatory topic, alleged violation, product name, letter type, and other text. The advanced search function includes a set of tips to help you quickly find the information you need.
You must be a subscriber to access this information. If you are a subscriber, please login. Not Yet A Subscriber? Click here to register for a free trial or contact Client Services at 800-677-3789 to activate your subscription.